Third Affiliated Hospital, Sun Yat-Sen University: Hepatitis B trials

The registry lists 37 Hepatitis B studies with Third Affiliated Hospital, Sun Yat-Sen University as lead sponsor. 7 are open to participants now and 0 have results posted.

Early Phase 1 1Phase 1 2Phase 2 2Phase 3 1Phase 4 12No phase 21(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Individual Nutrition Support in HBV-ACLF Patients at Nutrition RiskRecruitingNCT06128421Not applicable
• Combination of DPMAS and Low Volume PE for Patients With HBV Related ACLFRecruitingNCT04597164
• Long-term Prognosis of Patients With Hepatitis B Related Acute-on-chronic Liver FailureRecruitingNCT04310787
• Nucleoside (Acid) Analogues Treatment in Patients With Normal ALT and Positive HBVDNA.RecruitingNCT04231565Not applicable
• Three Types of Nucleotide/Nucleoside Analogues Treatment in HBV Related ACLFRecruitingNCT03920618Not applicable
• Therapeutic Effects and Long-term Follow-up After Ending Nucleos(t)Ide Analogs Therapy in Chronic Hepatitis bRecruitingNCT02883647
• Oral Vitamin D Treatment for the Prevention of Hepatocellular CarcinomaNot yet recruitingNCT02779465Phase 4
• Clinical Characteristics of RecompensationActive, not recruitingNCT07651683
• Effect of Serum Vitamin D Level on the Efficacy of Peg-interferon Treatment in CHBCompletedNCT05753280Phase 4
• Efficacy and Safety of Avatrombopag for Treating TCP in HBV-ACLF Patients Receiving ALSS TreatmentStatus unknownNCT05382013Phase 4
• TDF Combined With LDT for the Treatment of HBeAg-positive Hepatitis B Patients With Poor Response to TDF for 12 MonthsStatus unknownNCT04650828
• LDT Combined With TDF to Improve EGFR Decreasing in Patients With Chronic Hepatitis B Treated With TDFStatus unknownNCT04643990
• Efficacy and Safety of TAF in Pregnant Women With Chronic Hepatitis B InfectionStatus unknownNCT04507607Early Phase 1
• The Efficacy and Safety of TAF vs Other NAs in Patients With LVLStatus unknownNCT04501224Not applicable
• Three Types of Nucleotide/Nucleoside Analogues Therapy in Patients With Hepatitis b Virus Related Compensated CirrhosisStatus unknownNCT04196998Not applicable
• RL-1 Novel Human-derived Bio-artificial Liver Treatment in Patients of HBV Related ACLFStatus unknownNCT04195282Not applicable
• Three Types of Nucleotide/Nucleoside Analogues Therapy in Patients With Chronic Hepatitis bStatus unknownNCT04195074Not applicable
• The Clinical Cure Project of Chronic Hepatitis B in ChinaActive, not recruitingNCT04035837Phase 4
• Optimized Treatment of Peginterferon Alfa 2a in Treatment Experienced Patients With HBV Related Liver FibrosisStatus unknownNCT03957629Not applicable
• Optimized Treatment of Peginterferon Alfa 2a/2b in Treatment Experienced Patients With HBV Related Liver FibrosisStatus unknownNCT03920605Not applicable
• Optimized Treatment of Peginterferon Alfa 2a/2b in Anti-virus Treatment Naive Patients With HBV Related Liver FibrosisStatus unknownNCT03919565Not applicable
• The Optimizing Treatment of Peginterferon Alpha in Chronic Hepatitis B Patients With Low Level HBsAgStatus unknownNCT03801538Phase 4
• Optimal Treatment for Poor Efficacy of Entecavir in Chronic Hepatitis B PatientsStatus unknownNCT03733652Not applicable
• The Safety of Anti-viral Therapy in Preventing HBV MTCT in Pregnant Women After DiscontinuationCompletedNCT03468907Phase 4
• Radiomics for Diagnosing Liver Diseases and Evaluating ProgressionStatus unknownNCT03221049
• Peginterferon Alfa-2b Treatment in HBeAg(+) Chronic Hepatitis b Patients Based on Interferon Gene Mutation and Receptor DetectionStatus unknownNCT02973646Phase 4
• HBsAg Loss/Seroconversion in Low Replicative Chronic Hepatitis B Virus(HBV) Infection PatientsStatus unknownNCT02908763Phase 4
• The Optimizing Treatment of Peginterferon (PEG IFN) Alpha in Chronic Hepatitis B Virus Patients With Low Level HBsAgStatus unknownNCT02893124Phase 4
• The Optimizing Treatment of PegIFN Alfa in HBeAg-negative CHB Patients With Low Level HBsAgStatus unknownNCT02838810Phase 4
• Follow-up Strategy of Chronic Hepatitis B for Early Detection and Diagnosis of Hepatocellular Carcinoma: A Randomized Control TrialStatus unknownNCT02817685
• The Optimizing Treatment of PegIFN Alfa in HBeAg-negative CHB Patients With Low Level HBsAgStatus unknownNCT02745704Phase 4
• A Clinical Trial on Hepatitis B Vaccine Activated-Dendritic Cells Combined With Anti-HBV Drugs in CHBStatus unknownNCT02615639Phase 1/2
• New Strategy Study of Functional Cure of Chronic Hepatitis BStatus unknownNCT02605252Not applicable
• Entecavir Combined Short-term Intravenous Hepatitis B Immune Globulin (HBIG) to Prevent Hepatitis B Recurrence After Liver TransplantationStatus unknownNCT02417207Phase 4
• A Clinical Trial on HB-Vac Activated-DCs Combined With Peg-IFN or NAs in CHBCompletedNCT01935635Phase 1/2
• Efficacy and Safety of Peginterferon a-2a in Patients of Chronic Hepatitis B With Spontaneous Decline of HBV DNACompletedNCT01892241Phase 3
• Efficacy of Short-term Immunosuppressive Therapy and Anti-allergenic Therapy in Severe Acute Exacerbation of Chronic Hepatitis BStatus unknownNCT01627236Not applicable